Cherwell Software Announces Release of HR Service Management Solutions
Mar 30, 2017 12:03 pm UTC| Business
COLORADO SPRINGS, Colo., March 30, 2017 -- Cherwell Software announced today the release of two new Human Resources (HR) service management solutions for organizations interested in expanding the use of Cherwell®...
Achaogen to Present at Needham & Company’s 16th Annual Healthcare Conference
Mar 30, 2017 12:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 30, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today...
Achaogen to Present at Needham & Company’s 16th Annual Healthcare Conference
Mar 30, 2017 12:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 30, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today...
Mar 30, 2017 12:02 pm UTC| Business
DALLAS, March 30, 2017 -- Blue Calypso, Inc. (OTCQB:BCYP), an innovator of mobile consumer activation, engagement and social advocacy solutions for product brands and brick-and-mortar retailers, has filed a Form 15 with...
Tonix Pharmaceuticals Prices Public Offering of 1,800,000 Shares of Common Stock
Mar 30, 2017 12:02 pm UTC| Business
NEW YORK, March 30, 2017 -- Tonix Pharmaceuticals Holding Corp.(“Tonix”) (Nasdaq:TNXP), a company that is developing innovative pharmaceutical products to address public health challenges, announced today the pricing of...
Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit
Mar 30, 2017 12:02 pm UTC| Business
NEW YORK, March 30, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit
Mar 30, 2017 12:02 pm UTC| Business
NEW YORK, March 30, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...